Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 09:42 am Sale | 2025-03-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Frazier Life Sciences Public Fund, L.P. | 1,410,193 2.000% | -2,732,662 (-65.96%) | Filing |
| 2024-01-25 1:24 pm Purchase | 2024-01-23 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Frazier Life Sciences Public Fund, L.P. | 4,142,855 6.200% | 4,142,855 (New Position) | Filing |